212 related articles for article (PubMed ID: 36219353)
1. Constructed the ceRNA network and predicted a FEZF1-AS1/miR-92b-3p/ZIC5 axis in colon cancer.
Yang X; Wu P; Wang Z; Su X; Wu Z; Ma X; Wu F; Zhang D
Mol Cell Biochem; 2023 May; 478(5):1083-1097. PubMed ID: 36219353
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
Ma T; Chen H; Wang P; Yang N; Bao J
Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
[No Abstract] [Full Text] [Related]
3. Up-Regulated LncRNA FEZF1-AS1 Promotes the Progression of Cervical Carcinoma Cells via MiR-367-3p/SLC12A5 Signal Axis.
Yang X; Qu Y; Zhang J
Arch Med Res; 2022 Jan; 53(1):9-19. PubMed ID: 34362591
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA FEZF1-AS1 promotes rectal cancer progression by competitively binding miR-632 with FAM83A.
Xie R; Liu C; Liu L; Lu X; Tang G
Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):452-462. PubMed ID: 35607960
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA FEZF1-AS1 promotes cell growth in multiple myeloma via miR-610/Akt3 axis.
Li QY; Chen L; Hu N; Zhao H
Biomed Pharmacother; 2018 Jul; 103():1727-1732. PubMed ID: 29864963
[TBL] [Abstract][Full Text] [Related]
7. LncRNA FEZF1-AS1 Modulates Cancer Stem Cell Properties of Human Gastric Cancer Through miR-363-3p/HMGA2.
Hui Y; Yang Y; Li D; Wang J; Di M; Zhang S; Wang S
Cell Transplant; 2020; 29():963689720925059. PubMed ID: 32638620
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FEZF1-AS1 promotes colorectal cancer progression through regulating the miR-363-3p/PRRX1 pathway.
Zhang T; Yu S; Zhao S
Adv Clin Exp Med; 2021 Aug; 30(8):839-848. PubMed ID: 34286520
[TBL] [Abstract][Full Text] [Related]
11. LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma.
Zhou C; Jiang X; Liang A; Zhu R; Yang Y; Zhong L; Wan D
Neurosci Lett; 2021 Nov; 764():136245. PubMed ID: 34530115
[TBL] [Abstract][Full Text] [Related]
12. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
Yu M; Xue Y; Zheng J; Liu X; Yu H; Liu L; Li Z; Liu Y
Mol Cancer; 2017 Jun; 16(1):110. PubMed ID: 28651608
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway.
Fang J; Yang J; Chen H; Sun W; Xiang L; Feng J
Hum Cell; 2022 Sep; 35(5):1521-1534. PubMed ID: 35816228
[TBL] [Abstract][Full Text] [Related]
14. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer.
Liu HT; Ma RR; Lv BB; Zhang H; Shi DB; Guo XY; Zhang GH; Gao P
Br J Cancer; 2020 Jun; 122(12):1825-1836. PubMed ID: 32336754
[TBL] [Abstract][Full Text] [Related]
15. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
16. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p.
Hu C; Li S; Fu X; Zhao X; Peng J
Cytokine; 2023 Feb; 162():156105. PubMed ID: 36527891
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.
Geng S; Tu S; Fu W; Wang J; Bai Z
Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
